Generic and Innovative Drugs Market in CIS Countries 2014 - Russia, Ukraine and Kazakhstan Development forecasts for 2014-2019, New Report Launched

This report presents a comprehensive view of current conditions and key issues in the generic and innovative drugs market in Russia, Ukraine and Kazakhstan, as well as the analysis of all important recent and anticipated market trends and events.

It provides data describing the size of the market and of each segment, and analyses the impact of legal issues such as those regulating pricing, reimbursement, data exclusivity and patents.

The document also offers profiles of top companies, detailed forecasts for 2014-2019 and top selling products in the marketplace.

This report delivers:

• Yearly data describing the size of each segment during the period 2011-2015
• Data on market share of the generic and innovative drug segments in each country
• Forecasts for market growth and changes between 2014-2019
• Explanations of the country’s pricing and reimbursement rules
• Average and official price mark ups for generic and innovative medicines in Russia, Ukraine and Kazakhstan
• Expected changes to reimbursement lists
• Information on patent expirations and data exclusivity rules in each country
• Complete coverage of the counterfeit drug markets - regulations, market share and specific strategies used in Russia, Ukraine and Kazakhstan.

Benefit from the unique aspects of this report:

• Development forecasts for the generic and innovative drugs markets in each country and for each segment during the period 2014-2019
• Coverage of pricing and reimbursement procedures followed in each CIS country - Ukraine, Russia and Kazakhstan
• Complete range of vital information on this market compiled into one convenient and easy to access document.

Compare and analyse generic and innovative drug markets in CIS countries.Report provides comprehensive market data, forecasts for development to 2019. Now you can explore the prospects for growth in the generic and innovative drug markets in Russia, Ukraine and Kazakhstan quickly, conveniently and economically. Discover the value, recent growth and forecasts for expansion in both segments of each market, in each country, and gain valuable and usable information that contributes to a solid working knowledge of this market and its many complex issues.

Discover the market’s unique informational resource, Generic and innovative drugs market in CIS countries, Russia, Ukraine and Kazakhstan, development forecasts for 2014-2019. Review this publication today and enjoy the value and convenience of complete historical data, analysis of the latest and most critical issues driving market growth and professional evaluation of future market prospects in a single publication.

This document presents value data for each market segment during the period 2011-2019, analysis of the market share of the overall pharmaceutical sectors in each country occupied by generic and innovative medicines and detailed forecasts for opportunity in each of the three countries.

It delves into the pricing and reimbursement processes in each country, covers VAT rates and changes and keeps readers updated on upcoming adjustments to reimbursement schemes. It includes explanations of each country’s regulations with regard to data exclusivity and patent expirations and reviews the impacts of recent changes in other industry regulations on the CIS markets for generic and innovative drugs.

The report includes detailed profiles of the leading manufacturers of these medicines throughout the CIS region that name best-selling products in addition to supplying financial data. It provides input from physicians and patients on the generic and innovative drugs available, including their opinions about purchase and use of these specific types of treatments.

The report is very effective at clarifying regulatory conditions and processes utilised in the generic and innovative drug segments in each country. It examines current reimbursement procedures; pricing regulations and drug mark up rates, patent expiry and data exclusivity periods for medicines in each market. It enables quick and simple comparative analysis of generic and innovative drugs market conditions across Russia, Ukraine and Kazakhstan – compiled to meet the information needs of a variety of professionals.

This report is vital to the operations of generic and innovative drug manufacturers, potential participants evaluating the markets and preparing for entry and banking, investment and brokerage specialists with interests in the CIS pharma markets. It is useful to government agencies, business consultants, analysts and researchers, as well as chambers of commerce and organizations tasked with promotion of trade and commerce in this sector.

Generic and innovative drugs market in CIS countries, Russia, Ukraine and Kazakhstan, development forecasts for 2014-2019 provides essential support when conducting a variety of tasks, including making adjustments to product portfolios, launching new business ventures, comparing the regulatory conditions in each country and estimating growth potential in the generic and innovative drug markets in each country through 2019.

For more information visit at – http://mrr.cm/Z2C

Find all Generic Drugs Reports at: http://www.marketresearchreports.com/generic-drugs